MedTrace Logo

Identifying Molecular Drivers of Cancer

NCT02470715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 579

Last updated 2018-05-25

No results posted yet for this study

Summary

The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.

Conditions

Interventions

GENETIC

Molecular profile

Patients and their treating physician will obtain the patient's genetic risk assessment

Sponsors & Collaborators

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Brian Leyland-Jones · Avera McKennan Hospital & University Health Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-05-22
Completion
2018-05-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470715 on ClinicalTrials.gov